Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention

CIS43 is a potent neutralizing human mAb that targets a highly conserved “junctional” epitope in the Plasmodium falciparum (Pf) circumsporozoite protein (PfCSP). Enhancing the durability of CIS43 in vivo will be important for clinical translation. Here, 2 approaches were used to improve the durabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Kisalu, Neville K., Pereira, Lais D., Ernste, Keenan, Flores-Garcia, Yevel, Idris, Azza H., Asokan, Mangaiarkarasi, Dillon, Marlon, MacDonald, Scott, Shi, Wei, Chen, Xuejun, Pegu, Amarendra, Schön, Arne, Zavala, Fidel, Balazs, Alejandro B., Francica, Joseph R., Seder, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934869/
https://www.ncbi.nlm.nih.gov/pubmed/33332286
http://dx.doi.org/10.1172/jci.insight.143958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934869/
https://www.ncbi.nlm.nih.gov/pubmed/33332286
http://dx.doi.org/10.1172/jci.insight.143958

Ejemplares similares